Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 28.0T | 27.1T | 26.5T | 27.6T |
Cost of revenue | 21.9T | 21.4T | 20.4T | 20.9T |
Gross profit | 6.1T | 5.7T | 6.1T | 6.6T |
Operating expense | ||||
Research & development | — | 505.5B | 395.0B | 413.3B |
Selling general and admin | 3.1T | 1.9T | 2.3T | 2.0T |
Other operating expenses | — | 42.9B | 37.4B | 37.9B |
Operating income | 6.1T | 2.7T | 2.9T | 3.6T |
Non operating interest income | ||||
Income | — | 267.6B | 261.0B | 240.2B |
Expense | — | 23.0B | 23.9B | 18.8B |
Other income expense | — | — | — | — |
Pretax income | 3.2T | 2.4T | 3.2T | 4.0T |
Tax provision | 850.8B | 702.4B | 963.9B | 1.1T |
Net income | 2.4T | 1.7T | 2.3T | 3.0T |
Basic EPS | 6.0K | — | 5.8K | 7.5K |
Diluted EPS | 6.0K | — | 5.8K | 7.5K |
Basic average shares | — | — | 391.9M | 391.8M |
Diluted average shares | — | — | 391.9M | 391.8M |
EBITDA | 6.1T | 3.4T | 3.9T | 4.8T |
Net income from continuing op. | — | 1.7T | 2.3T | 3.0T |
Minority interests | 373M | 480M | -243M | -1.1B |
Preferred stock dividends | — | — | — | — |